Vanguard Capital Management
HSCS icon

Vanguard Capital Management’s Heart Test Laboratories HSCS Stock Holding History

Vanguard Capital Management’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.1K Hold
17,968
– – ﹤0.01% 3944
2026
Q1 		$44.2K Buy
+17,968
New +$52.3K ﹤0.01% 3930

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management's HSCS Position: Q2 2026 in Review

Vanguard Capital Management held its Heart Test Laboratories (HSCS) position steady in Q2 2026 at 17,968 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3944.

Vanguard Capital Management first reported a position in HSCS in Q1 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • Vanguard Capital Management held 17,968 shares of Heart Test Laboratories worth $45.1K as of Q2 2026.
  • Vanguard Capital Management left its Heart Test Laboratories share count unchanged in Q2 2026.
  • Heart Test Laboratories made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3944 holding.
  • Vanguard Capital Management first reported a position in Heart Test Laboratories in Q1 2026 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.